Logo image of PFSA

PROFUSA INC (PFSA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PFSA - US74319X1081 - Common Stock

0.1146 USD
+0.02 (+20.5%)
Last: 1/21/2026, 10:33:46 PM
0.1124 USD
0 (-1.92%)
After Hours: 1/21/2026, 10:33:46 PM
Fundamental Rating

0

PFSA gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. PFSA has a bad profitability rating. Also its financial health evaluation is rather negative. PFSA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • PFSA had negative earnings in the past year.
  • PFSA had a negative operating cash flow in the past year.
PFSA Yearly Net Income VS EBIT VS OCF VS FCFPFSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • With a Return On Assets value of -919.85%, PFSA is not doing good in the industry: 96.24% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -919.85%
ROE N/A
ROIC N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFSA Yearly ROA, ROE, ROICPFSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PFSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFSA Yearly Profit, Operating, Gross MarginsPFSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

  • PFSA has less shares outstanding than it did 1 year ago.
  • PFSA has a worse debt/assets ratio than last year.
PFSA Yearly Shares OutstandingPFSA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
PFSA Yearly Total Debt VS Total AssetsPFSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -73.81, we must say that PFSA is in the distress zone and has some risk of bankruptcy.
  • PFSA has a worse Altman-Z score (-73.81) than 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -73.81
ROIC/WACCN/A
WACCN/A
PFSA Yearly LT Debt VS Equity VS FCFPFSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.18 indicates that PFSA may have some problems paying its short term obligations.
  • PFSA's Current ratio of 0.18 is on the low side compared to the rest of the industry. PFSA is outperformed by 94.62% of its industry peers.
  • A Quick Ratio of 0.18 indicates that PFSA may have some problems paying its short term obligations.
  • PFSA's Quick ratio of 0.18 is on the low side compared to the rest of the industry. PFSA is outperformed by 94.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
PFSA Yearly Current Assets VS Current LiabilitesPFSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

  • PFSA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2241.21%.
EPS 1Y (TTM)-2241.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4641.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • PFSA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFSA Price Earnings VS Forward Price EarningsPFSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFSA Per share dataPFSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for PFSA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PROFUSA INC

NASDAQ:PFSA (1/21/2026, 10:33:46 PM)

After market: 0.1124 0 (-1.92%)

0.1146

+0.02 (+20.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-05
Earnings (Next)03-23
Inst Owners1.8%
Inst Owner Change3.99%
Ins Owners4.54%
Ins Owner Change0%
Market Cap7.53M
Revenue(TTM)N/A
Net Income(TTM)-39.09M
AnalystsN/A
Price TargetN/A
Short Float %20.44%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0
BVpS-0.52
TBVpS-0.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -919.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z -73.81
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2241.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4641.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1469.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-502.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-502.54%
OCF growth 3YN/A
OCF growth 5YN/A

PROFUSA INC / PFSA FAQ

Can you provide the ChartMill fundamental rating for PROFUSA INC?

ChartMill assigns a fundamental rating of 0 / 10 to PFSA.


What is the valuation status for PFSA stock?

ChartMill assigns a valuation rating of 0 / 10 to PROFUSA INC (PFSA). This can be considered as Overvalued.


Can you provide the profitability details for PROFUSA INC?

PROFUSA INC (PFSA) has a profitability rating of 0 / 10.


What is the financial health of PROFUSA INC (PFSA) stock?

The financial health rating of PROFUSA INC (PFSA) is 0 / 10.